Top

Published in:

01-12-2010 | Editorial Review

Systematic review of randomized controlled trial quality in pediatric kidney transplantation

Authors: Robert J. Brooks, Gail Y. Higgins, Angela C. Webster

Published in: Pediatric Nephrology | Issue 12/2010

Abstract

Limited pediatric-specific research can lead to sub-standard evidence for clinical decision making in children. We sought to systematically evaluate the methodological quality and the reporting standards of randomized controlled trials (RCTs) of transplantation trials in children. We included RCTs of kidney transplant recipients that had enrolled at least one child (aged 17 years or less) and that were reported in English language, peer reviewed journals from 2000 onward in the Cochrane Renal Group’s specialized register. Trial reports were assessed against the 22 item checklist of the CONsolidated Standards Of Reporting Trials (CONSORT) statement. Twenty-seven RCTs were included. The reporting of the essential components of the methods, results and discussion domains was unsatisfactory. Mean CONSORT criteria score for the pediatric trials was 67% and 66% for trials including both adults and children (p value for the difference = 1.00). Trial reporting quality in pediatric transplantation trials is not different from trials involving adults. It is evident that the reporting standards of RCTs in both adult and pediatric transplantation require major improvements. This work bench-marks current standards for future quality improvement.

McTaggart S, Kennedy S, McDonald S, Henning P, Dent H (2008) Pediatric report. In: MacDonald S, Excell L, Livingston B (eds) The thirty-first report: Australia and New Zealand Dialysis and Transplant Registry 2008. ANZDATA Registry, Adelaide

Milliner D (2004) Pediatric renal-replacement therapy—coming of age. N Engl J Med 350:2637–2639CrossRefPubMed

McDonald S, Craig J (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350:2654–2662CrossRefPubMed

Wilson J (1999) An update on the therapeutic orphan. Pediatrics 104:585–590PubMed

Caldwell P, Murphy S, Butow P, Craig J (2004) Clinical trials in children. Lancet 364:803–811CrossRefPubMed

Altman D, Schulz K, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T; CONSORT Group (Consolidated Standards of Reporting Trials) (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663–694PubMed

Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP (1998) Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609–613CrossRefPubMed

Moher D, Schulz K, Altman D (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 357:1191–1194CrossRefPubMed

Moher D, Jones A, Lepage L (2001) Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. The CONSORT Group. JAMA 285:1992–1995CrossRefPubMed

10.

Kane R, Wang J, Garrard J (2007) Reporting in randomized clinical trials improved after adoption of the CONSORT statement. J Clin Epidemiol 60:241–249CrossRefPubMed

11.

Stinson J, McGrath P, Yamada J (2003) Clinical trials in the Journal of Pediatric Psychology: applying the CONSORT statement. J Pediatr Psychol 28:159–167CrossRefPubMed

12.

Al-Namankany A, Ashley P, Moles D, Parekh S (2009) Assessment of the quality of reporting randomized clinical trials in pediatric dentistry journals. Int J Paediatr Dent 19:318–324CrossRefPubMed

13.

Moher D, Soeken K, Sampson M, Ben-Porat L, Berman B (2002) Assessing the quality of reports of randomized controlled trials in pediatric complementary and alternative medicine. BMC Pediatr 2:2CrossRefPubMed

14.

Anttila H, Malmmivaara A, Kunz R, Autti-Ramo L, Makela M (2006) Quality of reporting randomized controlled trials in cerebral palsy. Pediatrics 117:2222–2230CrossRefPubMed

15.

Curtis J, Kaplan B (2004) Transplant immunosuppressive drug trials on trial. Am J Transplant 4:671–672CrossRefPubMed

16.

Fritsche L, Einecke G, Fleiner F, Dragun D, Neumayer H, Budde K (2004) Reports of large immunosuppression trials in kidney transplantation: room for improvement. Am J Transplant 4:738–743CrossRefPubMed

17.

Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I (2006) Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. Med J Aust 185:263–267PubMed

18.

Ferraris JR, Pasqualini T, Legal S, Sorroche P, Galich AM, Pennisi P, Domene H, Jasper H (2000) Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group. Pediatr Nephrol 14:682–688CrossRefPubMed

19.

Fine R, Stablein D, Cohen A, Tejani A, Kohaut E (2002) Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 62:688–696CrossRefPubMed

20.

Sanchez C, Kuizon BD, Goodman WG, Gales B, Ettenger RB, Boechat MI, Wang Y, Elashoff R, Salusky IB (2002) Growth hormone and the skeleton in pediatric renal allograft recipients. Pediatr Nephrol 17:322–328CrossRefPubMed

21.

Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 17:141–149CrossRefPubMed

22.

El Husseini A, El Agroudy A, El Sayed M, Sobh M, Ghoneim M (2004) Treatment of osteopenia and osteoporosis in renal transplant children and adolescents. Pediatr Transplant 8:357–361CrossRefPubMed

23.

Benfield M, Tejani A, Harmon W, McDonald R, Stablein DM, McIntosh M, Rose S, CCTPT Study Group (2005) A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation. Pediatr Transplant 9:282–292CrossRefPubMed

24.

Grenda R, Watson A, Vondrak K, Webb NJ, Beattie J, Fitzpatrick M, Saleem MA, Trompeter R, Milford DV, Moghal NE, Hughes D, Perner F, Friman S, Van Damme-Lombaerts R, Janssen F (2006) A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant 6:1666–1672CrossRefPubMed

25.

Smith J, Wong CS, Salamonik EB, Hacker BM, McDonald RA, Mancl LA, Williams BJ, Ibrahim A, Roberts FA (2006) Sonic tooth brushing reduces gingival overgrowth in renal transplant recipients. Pediatr Nephrol 21:1753–1759CrossRefPubMed

26.

Cransberg K, Cornelissen M, Lilien M, Van H, Davin J, Nauta J (2007) Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk. Transplantation 83:1041–1047CrossRefPubMed

27.

Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE (2000) Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 69:834–841CrossRefPubMed

28.

Kahan B (2000) Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicenter study. Lancet 356:194–202CrossRefPubMed

29.

Legendre C, Norman D, Keating M, Maclaine G, Grant D (2000) Valaciclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluation. Transplantation 70:1463–1468CrossRefPubMed

30.

Antonopoulos I, Nahas W, Mazzucchi E, Ianhez L, Saldanha L, Arap S (2001) Comparison of palpation-guided and ultrasound-guided biopsies in transplanted kidneys. Clin Transplant 15:393–396CrossRefPubMed

31.

Henry M, Pelletier R, Elkhammas E, Bumgardner G, Davies E, Ferguson R (2001) A randomized prospective trial of OKT3 induction in the current immunosuppression era. Clin Transplant 15:410–414CrossRefPubMed

32.

Johnson R, Kreis H, Oberbauer R, Brattstrom C, Claesson K, Eris J (2001) Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 72:777–786CrossRefPubMed

33.

Kahan B, Kaplan B, Lorber M, Winkler M, Cambon N, Boger R (2001) RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection. Transplantation 71:1400–1406CrossRefPubMed

34.

MacDonald A (2001) A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 71:271–280CrossRefPubMed

35.

Montagnino G, Tarantino A, Segoloni GP, Cambi V, Rizzo G, Altieri P, Castagneto M, Salvadori M, Cossu M, Pisani F, Carmellini M, Mastrangelo F, Ferrara R, Ponticelli C (2001) Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation. J Am Soc Nephrol 12:2163–2169PubMed

36.

Zhang X, Ardissino G, Ghio L, Tirelli AS, Daccò V, Colombo D, Pace E, Testa S, Claris-Appiani A (2001) L-arginine supplementation in young renal allograft recipients with chronic transplant dysfunction. Clin Nephrol 55:453–459PubMed

37.

Kumana C, Tong M, Li C, Lauder IJ, Lee JS, Kou M, Walley T, Haycox A, Chan TM (2003) Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin. Br J Clin Pharmacol 56:670–678CrossRefPubMed

38.

Ciancio G, Burke G, Gaynor JJ, Ruiz P, Roth D, Kupin W, Rosen A, Miller J (2006) A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis. Transplantation 81:845–852CrossRefPubMed

39.

El Dahshan K, Bakr M, Donia A, Badr A, Sobh M (2004) Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: a prospective randomized study. Nephrol Dial Transplant 19:1613–1617CrossRefPubMed

40.

Machado P, Felipe CR, Hanzawa NM, Park SI, Garcia R, Alfieri F, Franco M, Silva HT Jr, Medina-Pestana JO (2004) An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone. Clin Transplant 18:28–38CrossRefPubMed

41.

Nashan B, Curtis J, Ponticelli C, Mourad G, Jaffe J, Haas T (2004) Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study. Transplantation 78:1332–1340CrossRefPubMed

42.

Lorber M, Mulgaonkar S, Butt KM, Elkhammas E, Mendez R, Rajagopalan PR, Kahan B, Sollinger H, Li Y, Cretin N, Tedesco H, B251 Study Group (2005) Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study. Transplantation 80:244–252CrossRefPubMed

43.

Gurkan A, Yakupoglu YK, Dinckan A, Erdogdu T, Tuncer M, Erdoğan O, Demirbas A, Akaydin M (2006) Comparing two ureter reimplantation techniques in kidney transplant recipients. Transpl Int 19:802–806CrossRefPubMed

44.

Silva H, Yang H, Abouljoud M, Kuo PC, Wisemandle K, Bhattacharya P, Dhadda S, Holman J, Fitzsimmons W, First MR (2007) One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. Am J Transplant 7:595–608CrossRefPubMed

45.

Moher D, Fortin P, Jadad AR, Jüni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A (1996) Completeness of reporting of trials published in languages other than English: implications for the conduct of systematic reviews. Lancet 347:363–366CrossRefPubMed

46.

Budde K, Fritsche L (2005) Proposal for guidelines for publication of randomized trials in the American Journal of Transplantation. Am J Transplant 5:644–647CrossRefPubMed

47.

Martini S, Glander P, Fritsche L, Fleiner F, Budde K (2007) Suggested guidelines for reporting clinical results in transplantation trials. Transplant Rev 21:136–142CrossRef

Title: Systematic review of randomized controlled trial quality in pediatric kidney transplantation
Authors: Robert J. Brooks
Gail Y. Higgins
Angela C. Webster
Publication date: 01-12-2010
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 12/2010
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-010-1595-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Systematic review of randomized controlled trial quality in pediatric kidney transplantation

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2010

CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency

Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease

Regression of target organ damage in children and adolescents with primary hypertension

Factors modifying the association between birth weight and blood pressure

Neurological involvement in a child with atypical hemolytic uremic syndrome

Acute kidney injury: can we improve prognosis?